Tag

Alison Moore

Panel: Biotech Manufacturing Industrialization, Talent Development, and Leadership — A Tribute to Our Friend Mike Kamarck
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Panel: Biotech Manufacturing Industrialization, Talent Development, and Leadership — A Tribute to Our Friend Mike Kamarck

November 22, 2023

Over the last few decades we have all witnessed the industrialization of biologics manufacturing, as well as continuous progress in complex medicines such as Cell and Gene Therapy. In this panel we will reflect on where we started, where we are now, and what our future holds. We dedicate this conversation to Mike Kamarck, an exceptional leader of our era whose legacy includes everything we plan to discuss: Alison MooreCMC Executive Dr. Alison Moore is a CMC Executive who most recently served as the Chief Technical Officer at Allogene Therapeutics. Prior to this role, Moore served as Senior Vice President,…

Continue reading
Leave a comment
Welcome Day Panel: Planning for Biomanufacturing of the Future: What are the Five Big Things We Need to Talk About?
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Welcome Day Panel: Planning for Biomanufacturing of the Future: What are the Five Big Things We Need to Talk About?

November 22, 2023

— Moderator: Alison MooreCMC Executive Dr. Alison Moore is a CMC Executive who most recently served as the Chief Technical Officer at Allogene Therapeutics. Prior to this role, Moore served as Senior Vice President, Process Development, in Amgen Operations. Moore was previously vice president, Process and Product Engineering (P&PE), where she was responsible for Process Development, Clinical Operations and Global Operations Planning. Moore served as vice president, Corporate Manufacturing, overseeing Supply Chain, Contract Manufacturing, Global Distribution, Manufacturing Technologies, and Operations Risk Management. Before taking on this position, she was vice president, Site Operations at Amgen’s Fremont, California, manufacturing facility (AFR)….

Continue reading
Leave a comment
Fireside Chat: Building the Future from a Distinguished Tenure in CMC
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Fireside Chat: Building the Future from a Distinguished Tenure in CMC

November 23, 2022

Introducing Prime Medicine and its vision for the future of medicine How are we thinking about the inclusion of novel types of automation into molecular medicine workflows? Examining how we view Talent in the emergent technology space, and how do we best deploy remote and hybrid work? Historically, pharmaceutical manufacturing leaders were predominantly men; however, many important CMC leadership positions are now held by women. Why is this the case, and how do we sustain this pattern? What are the most significant learnings from having achieved success in licensing autologous cell therapies? — Ann Lee Chief Technical Officer Prime Medicine…

Continue reading
Leave a comment
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Panel: Looking Backwards, Looking Forwards: Maximizing Our Impact on the Future of Medicine

November 28, 2022

The past few years has seen a migration of talent and technology from traditional biopharmaceutical manufacturing to ATMP manufacturing: How has this changed the CMC ecosystem, and are we overbuilding capacity again? Avoiding the dangers of fragmentation. How should we better communicate, collaborate, and consolidate our best ideas so we all succeed? Discussing the reasons to set up a new company today, and imagining how our business ecosystem will continue to grow and evolve Debating which production platforms will best suit the newer modalities Exploring the next steps for existing platforms like mAbs: How do we efficiently serve giant markets…

Continue reading
Leave a comment
Panel: Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Panel: Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?

December 1, 2020

Debating the merits of nimble and flexible facilities versus manufacturing battleships Preparing your pilot plants and manufacturing facilities to move forward with Phase II-III approvals Forecasting requirements for optimizing manufacturing equipment, facilities and partners to increase speed to market Achieving business goals to better manage times of product and economic uncertainty Putting theory into practice: Implementing key metrics to improve manufacturing flexibility — Moderators: Pat Yang Chairman at Acepodia & Founding Board Director at Sana Biotechnology Dr. Patrick Y. Yang has over 35 years leadership experience in technology, manufacturing, supply chain, and operational management functions in General Electric, Merck, Genentech,…

Continue reading
Leave a comment
BMWS20 – Opening Chairs’ Remarks and Keynote: Reinventing a Biopharma Company for the 21st Century
LIFE SCIENCES, LIFE SCIENCES, VIDEO

BMWS20 – Opening Chairs’ Remarks and Keynote: Reinventing a Biopharma Company for the 21st Century

December 1, 2020

Bristol Myers Squibb is a company that has undergone an extensive transformation and as a result, has reinvented itself Once a company consisting of multiple and vastly different business units, it is now the largest diversified specialty global biopharma company Its mission and focus is to utilize innovation to advance the treatment of serious disease and significant unmet medical need This organizational evolution required substantial change for the product development and manufacturing arms of the company Technology, systems, processes, people and culture all needed to be re-evaluated through a “new lens” The presentation will cover this journey including approach, successes,…

Continue reading
Leave a comment
Keynote: When Your Process Equipment is a Raw Material and Your Raw Material is a Human: The Adaptation of Biotechnology CMC Skills to Cell Therapy
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Keynote: When Your Process Equipment is a Raw Material and Your Raw Material is a Human: The Adaptation of Biotechnology CMC Skills to Cell Therapy

February 19, 2020

CMC/Operations disciplines have an important role in the commercialization of powerful new cell therapies Well understood development principles can be applied, though there are challenges It is important to identify when to draw on experience and when to adapt/grow to address gaps Comparability is key in an emergent technology space, but may be limited by product understanding Growing development skills to advance important new medicines — Alison Moore Chief Technology Officer Allogene Therapeutics Dr. Alison Moore is Chief Technical Officer at Allogene Therapeutics. Prior to this role, Moore served as senior vice president, Process Development,in Amgen Operations. Moore was previously…

Continue reading
Leave a comment
Panel: Setting Ambitious Goals to Improve the Biopharmaceutical Ecosystem
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Panel: Setting Ambitious Goals to Improve the Biopharmaceutical Ecosystem

November 20, 2019

Discussing the growing regulatory complexity in the world of pharmaceutical manufacturing. How are new guidelines and regulators’ expectations during inspections changing? Taking a process-based approach to impact assessment, and customizing a setup that identifies and acts on signals proactively Bringing a structured approach to your advocacy within your network of industry and trade organization connections Embracing the idea that keeping things simple even in a complex environment generates the best outcomes — Pat Yang Former EVP at Juno Therapeutics, Roche and Genentech Dr. Patrick Y. Yang has over 35 years leadership experience in technology, manufacturing, supply chain, and operational management…

Continue reading
Leave a comment
Panel: The Global Talent War in Biomanufacturing
LIFE SCIENCES, VIDEO

Panel: The Global Talent War in Biomanufacturing

November 8, 2018

Learning about global talent trends influencing the job market for senior executives and those with critical, specialized skill sets Creating effective attraction, retention and development plans for top talent Navigating the generational talent gap in critical functions Understanding which leadership differentiators are needed to make it to Senior Executive and C-Level roles — Sanat Chattopadhyay EVP & President, Merck Manufacturing Division Merck Sanat Chattopadhyay is responsible for Merck’s worldwide manufacturing and supply operations supporting annual global sales revenues exceeding $40 billion. Merck is known as MSD outside of the U.S. and Canada. Sanat oversees a network of 50 pharmaceuticals, vaccines,…

Continue reading
8 Comments
The Role of Process Development in Next Generation Biologics Manufacturing
LIFE SCIENCES, VIDEO

The Role of Process Development in Next Generation Biologics Manufacturing

December 13, 2016

Alison Moore delivered the opening keynote on November 15th of the 2016 edition of the Biomanufacturing World Summit entitled, The Role of Process Development in Next Generation Biologics Manufacturing. Dr. Alison Moore is Senior Vice President, Process Development serving both Operations and R&D organizations. Prior to this role, Moore served as senior vice president, Operations Technology. Moore was previously vice president, Process and Product Engineering (P&PE) function, where she was responsible for Process Development, Clinical Operations and Global Operations Planning. Moore served as vice president, Corporate Manufacturing, overseeing Supply Chain, Contract Manufacturing, Global Distribution, Manufacturing Technologies, and Operations Risk Management….

Continue reading
Leave a comment

  • NASCES

  • NAFS

  • NAFMS

  • EUSCES

  • BMWS

  • NAFES

  • NASRS

  • NAMES

  • PMWS

  • NAISS

  • NAHRES